To evaluate the clinical benefit of extended endocrine therapy after 5 years of adjuvant treatment with LHRHa in premenopausal women with node-positive, HR-positive early breast cancer.

Menopause can accelerate age-related weight gain, increasing a woman’s odds of becoming overweight or obese, researchers said ...

Tirzepatide users on hormone therapy had added improvements in weight, cardiometabolic mar ...

PrECOG, LLC, today announced the publication of final results from the pivotal phase 3 PATINA study in the New England ...

Adding Ibrance to maintenance therapy extends progression-free survival by 15.2 months in HR-positive, HER2-positive ...

Investigators sought to describe the patterns of post-progression outcome for patients with HR+/HER2- advanced breast cancer treated with endocrine therapy and a CDK4/6 inhibitor.

A new study led by Mayo Clinic found that postmenopausal women receiving menopausal hormone therapy lost 35% more weight ...

The novel oral selective estrogen receptor (ER) degrader giredestrant significantly reduced the risk of invasive disease ...

Hormone therapy involves administering hormones to address imbalances, alleviate symptoms of hormonal deficiencies, and significantly enhance quality of life.

For years, women have been told to “tough it out” through menopause—doctors are finally calling BS.

Hormone therapy isn’t about “fixing” the body but supporting it with an achievable routine. When combined with sleep, ...

Experts explain the latest research.